Spenser Lin No Comments

Healthcare News, Deals, and Investments Update Jun 22nd, 2026

LECO_Weekly-Healthcare-News_6-22-2026Download
  1. Apollo Global-Backed Thoreau Group Signs Definitive Agreement for Strategic Growth Investment in Ensemble Health Partners, the Nation’s Largest RCM Managed Services Provider, at an Approximately $12 Billion Valuation Thoreau Group — the healthcare investment platform founded by former New Mountain Capital executive Matt Holt and backed by Apollo Global Management — signed a definitive agreement on June 17–18, 2026 to make a strategic growth investment in Ensemble Health Partners at an estimated $12 billion valuation. Ensemble manages more than $55 billion in net patient revenue annually across 200+ hospitals and approximately 12,000 employees, serving major health systems through billing, payment, and AI-enabled RCM services — including an RCM-native large language model developed in partnership with Cohere — following a $4.75 billion dividend recapitalization completed in January 2026. Legacy investors Berkshire Partners, Warburg Pincus, and Bon Secours Mercy Health will continue as co-investors. The transaction positions Thoreau at the center of the scaled healthcare administrative outsourcing sector. (Link)
  2. Abry Partners has closed a $780 million single-asset continuation fund anchored by Neuberger Berman and Apollo S3 (NYSE: APO) to retain its investment in Centauri Health Solutions, while simultaneously divesting Centauri’s Provider Solutions business to Elevate, a portfolio company of Audax Private Equity and Parthenon Capital Partners. Boston-based private equity firm Abry Partners orchestrated a $780 million single-asset continuation fund to extend its ownership of Centauri Health Solutions — a healthcare technology company serving U.S. health plans and health systems — transferring the asset from Abry Fund IX into the new vehicle. The Continuation Fund was co-anchored by Neuberger Berman and Apollo S3 (NYSE: APO), with additional commitments from Abry’s existing LP base. Concurrently, Centauri’s Provider Solutions business was divested to Elevate, a portfolio company of Audax Private Equity and Parthenon Capital Partners, sharpening Centauri’s focus as a pure-play payer technology and data intelligence platform. Since Abry’s 2020 investment, Centauri’s payer business tripled revenue and quadrupled EBITDA. (Link)
  3. Altaris has agreed to acquire Simulations Plus (Nasdaq: SLP) for approximately $375 million in an all-cash transaction, representing a 26% premium to the company’s 60-day volume-weighted average price, with the deal expected to close in Q4 2026. New York-based Altaris, an investment firm managing over $9 billion in equity capital with an exclusive focus on healthcare, has entered into a definitive agreement to acquire Simulations Plus (Nasdaq: SLP) at $18.50 per share in cash. Altaris anticipates combining the target with Chemical Computing Group (CCG), an existing Altaris portfolio company focused on molecular design software, to create a more integrated AI-driven drug development platform. The all-cash transaction, unanimously approved by Simulations Plus’s board, is financed through committed equity and debt from Altaris-affiliated funds without a financing contingency. Simulations Plus co-founder Dr. Walter Woltosz has entered into a voting support agreement backing the deal. The transaction is expected to close in Q4 2026 subject to stockholder and regulatory approvals. (Link)
  4. Abarca Health and LucyRx Announce Strategic Combination to Create the Only Modern PBM Built for Commercial and Government Scale Abarca Health and LucyRx have announced a strategic combination to form a modern, independent pharmacy benefit manager (PBM) with the scale and technology to serve commercial and government clients nationwide. The combined entity, operating under the parent brand Healthcare Revolution Partners, will provide prescription services to more than 9 million members. Abarca contributes its Darwin Healthcare Intelligence platform — a cloud-native, configurable PBM technology stack — while LucyRx brings clinical capabilities and deep expertise serving employers and labor groups. Both brands will continue operating as subsidiaries with no disruption to clients or members. The combination arrives amid ongoing scrutiny of traditional PBM consolidation and demand for transparent, independent alternatives. (Link)
  5. Singlepoint Healthcare Acquires Healix, Expanding National Infusion Capabilities Singlepoint Healthcare has acquired Healix, a leading provider of outpatient infusion management services operating more than 220 physician-owned and ambulatory infusion centers nationwide. The deal enhances Singlepoint’s integrated care model for inflammatory diseases by adding specialized infusion services spanning infectious disease, gastroenterology, neurology, rheumatology, and related therapeutic areas. This marks Singlepoint’s third acquisition in the past year, reflecting an accelerated buy-and-build strategy in the outpatient infusion market — a high-growth segment driven by biosimilar adoption, site-of-care migration from hospitals to lower-cost settings, and increasing prevalence of chronic inflammatory conditions. Healix will continue its focus on optimizing patient care in outpatient settings following integration. (Link)
  6. Aldrich Capital Partners-backed Compliancy Group has acquired Healthicity, a leading provider of healthcare compliance and auditing software, to create the most comprehensive combined platform for healthcare compliance programs serving more than 3,000 healthcare organizations. Compliancy Group, the healthcare compliance SaaS platform backed by growth equity investor Aldrich Capital Partners, has acquired Healthicity, a provider of healthcare auditing and compliance software including Compliance Manager and Audit Manager+ solutions. The combination creates the first unified platform delivering end-to-end coverage of provider, coding, and documentation auditing alongside workforce compliance, risk assessment, and incident management for a combined customer base exceeding 3,000 U.S. healthcare organizations (Link)
  7. ChartSpan Acquires Validic, the Leading Personal Health Data Platform, Creating a Unified Clinical Care Management and Remote Patient Monitoring Platform for Health Systems, Payers, and Life Sciences Companies Greenville, SC-based ChartSpan, a leading care management services company, announced on June 22, 2026 the completed acquisition of Validic, the healthcare industry’s leading personal health data platform connecting wearable and clinical devices to health system workflows. The combined company unites ChartSpan’s clinical care teams and Chronic Care Management, Advanced Primary Care Management, and Remote Patient Monitoring services with Validic’s global IoT and health data API infrastructure, device logistics, and RPM software — enabling organizations to move from periodic observation to continuous patient understanding. (Link)
  8. Ohio-based Align Capital Partners’ portfolio company Premier Biotech (based in Cleveland, Ohio and Dallas, Texas) has acquired both NexScreen and TransMed, representing the firm’s seventh acquisition since partnering with ACP in November 2022. Cleveland, Ohio-based Align Capital Partners (ACP), a growth-oriented private equity firm managing $3.2 billion in committed capital, has executed two simultaneous bolt-on acquisitions through its drug and alcohol testing portfolio company Premier Biotech: NexScreen, a point-of-care diagnostic testing solutions provider operating across the U.S., Australia, and New Zealand; and TransMed, a broad-catalog drug testing and lab supply distributor with over 1,000 direct customer accounts and a global e-commerce platform. These transactions mark Premier Biotech’s sixth and seventh acquisitions under ACP’s ownership since November 2022, extending the company’s international footprint and product offering across healthcare, government, and workplace markets. (Link)
  9. Cleargate Capital Partners has made a strategic investment in Fellow Health Partners, a Bay Shore, New York-based provider of revenue cycle management services to more than 500 clinicians across approximately 50 healthcare organizations nationwide. Healthcare-focused private equity firm Cleargate Capital Partners, founded in 2025, has made an undisclosed strategic investment in Fellow Health Partners, a leading RCM services provider to physician groups, ambulatory surgery centers, and specialty healthcare organizations across the U.S. Cleargate’s investment is intended to fund growth across Fellow’s SAVi technology platform,capital to pursue add-on acquisitions. Fellow’s existing management team, led by CEO Michael N. Brown, will continue to lead the organization. The deal supports Cleargate’s thesis of backing founder-led, lower-middle-market healthcare businesses with partnerships. (Link)
  10. AI-Native Medicare Navigation Platform Connie Health Completes Acquisition of Clearlink’s Medicare Business — Its 10th Acquisition — Alongside a $40 Million Series B Led by HealthQuest Capital, Bringing Total Funding to $85 Million Boston-based Connie Health, the AI-native Medicare navigation platform, has completed its acquisition of Clearlink Insurance Agency’s Medicare business — its 10th acquisition — while closing a $40 million Series B led by HealthQuest Capital with participation from JSL Capital, Khosla Ventures, aMoon, and Pitango HealthTech. The round brings total funding to $85 million. The integration leverages Connie’s AI and automation platform to seamlessly absorb the large-scale book while maintaining personalized service through its network of local trusted agents. Capital will support continued national expansion, technology investment, and additional acquisitions as Connie deepens its role as a strategic partner for value-based care organizations and ACOs. (Link)
  11. Tredence Acquires KMK Consulting, a Morris Plains, NJ-Based Life Sciences Analytics Firm Serving 8 of the World’s Top 10 Pharmaceutical Companies, to Build a Scaled Healthcare and Life Sciences AI Platform Tredence, a global AI and data science solutions firm, has acquired KMK Consulting, a specialized analytics and consulting firm with deep expertise in pharmaceuticals and life sciences headquartered in Morris Plains, New Jersey. KMK partners with 8 of the world’s top 10 pharmaceutical companies and brings over two decades of domain expertise in commercial analytics, real-world evidence (RWE), and market research. The deal positions Tredence to expand its Healthcare & Life Sciences business by combining KMK’s domain depth with Tredence’s Agentic AI capabilities across the full molecule-to-market development journey. (Link)
  12. Interlock Equity-Backed VeloSource Simultaneously Acquires Quest Locum Tenens and Syncx LLC, Adding National Physician Staffing Scale and a Proprietary Vendor-Neutral Workforce Management Technology Platform St. Louis-based VeloSource LLC, a portfolio company of Interlock Equity, has acquired Quest Locum Tenens and Syncx LLC to build an enterprise healthcare workforce ecosystem. The deals expand VeloSource’s national clinical staffing capabilities and add Syncx’s proprietary vendor-neutral technology platform for workforce management, including a differentiated physician float pool model that digitizes scheduling and prioritizes internal resources before external placement. Quest brings additional nationwide placement expertise for physicians, nurse practitioners, physician assistants, and CRNAs. The combined platform aims to address clinician shortages and improve operational efficiency for healthcare organizations. (Link)
  13. Avista Healthcare Partners-backed EBI has acquired Xstim, a division of Precision Medical Products Inc., to expand its bone growth stimulation portfolio and reinforce its position as the only pure-play bone growth stimulation company. EBI, a portfolio company of New York-based Avista Healthcare Partners — which has invested over $10 billion across more than 50 healthcare businesses globally — has acquired Xstim, the bone healing division of Precision Medical Products Inc. Xstim’s next-generation, wearable, capacitively coupled electrical stimulation therapy for lumbar spinal fusion is highly complementary to EBI’s existing FDA-approved portfolio of implantable and non-invasive bone healing solutions, including the EBI® Bone Healing System, OrthoPak®, and SpinalPak®. The deal advances Avista’s strategy of building differentiated, growth-oriented healthcare product platforms with clear scale potential and broadens EBI’s total addressable market across spinal fusion, nonunion fracture, and joint fusion applications. (Link)
  14. HR HealthCare Acquires SteriGear LLC and Fig Leaf Brand, Expanding Urology Solutions Across the Care Continuum York, PA-based HR HealthCare has acquired SteriGear LLC, including the Fig Leaf brand of urinary drainage devices and related covers and drapes, to strengthen its bladder management portfolio across acute, post-acute, and home care settings. The Fig Leaf product emphasizes patient dignity with privacy features, while SteriGear’s solutions complement HR HealthCare’s TruCath line. The deal creates a more comprehensive urology platform accessible through a single source, consolidating procurement for hospital systems and post-acute care providers. The Fig Leaf brand will continue operating under its existing name, with the SteriGear brand transitioning into HR HealthCare’s portfolio over time. (Link)
  15. Michigan Ear Institute Partners with Align ENT & Allergy, Expanding Access to Specialized Ear, Hearing, and Balance Care Across Michigan and Ohio Under a Physician-Led MSO Model Michigan Ear Institute (MEI), headquartered in Farmington Hills, Michigan, has entered into a strategic partnership with Align ENT & Allergy, a physician-led management services organization. The transaction closed on March 25, 2026, and expands access to specialized ear, hearing, and balance care across Michigan and Ohio. MEI operates four locations and is recognized for advanced diagnostic and treatment options. The partnership aligns MEI with Align’s MSO model focused on operational support, billing, and practice management while preserving full clinical autonomy for its physicians. (Link)
  16. Brightstar Capital Partners Acquires Erdman, a Madison, WI-Based Architecture and Engineering Firm Specializing in Healthcare Facilities and Senior Living Communities, to Expand Its Architecture and Design Platform Brightstar Capital Partners has acquired Erdman, a Madison, Wisconsin-based architecture and engineering firm founded in 1951 specializing in healthcare facilities and senior living communities. Licensed in more than 45 states, Erdman joins KZF Design in Brightstar’s architecture and design platform and contributes its proprietary ZeroIn healthcare analytics platform — a data-driven tool for optimizing facility design and operational performance. The deal supports growing demand for healthcare and senior living construction driven by an aging population and expands Brightstar’s national footprint in healthcare facility design and development. (Link)
  17. PruittHealth Acquires Four Home Health Offices in South Georgia, Adding 36 Counties to Expand Its Statewide Service Area to 109 Counties Under the PruittHealth @ Home Brand PruittHealth has acquired four home health offices in South Georgia — Community Health Services of Georgia locations in Vidalia and Albany, and Georgia Home Health Services locations in Valdosta and Tifton — adding 36 counties to its service area for a total of 109 counties statewide. The acquired offices will operate under the PruittHealth @ Home brand and integrate into PruittHealth’s existing home health network. This expansion reinforces PruittHealth’s position as a leading provider of home health services across Georgia, continuing the organization’s strategy of geographic densification within its core market through targeted acquisitions of established home health agencies. (Link)
  18. Jennie Stuart Health Acquires Six Medical Practices Across Western Kentucky, Including Generations Primary Care, MDVIP, Hopkinsville Family Care, and Three Additional Clinics, Strengthening Regional Provider Coordination Jennie Stuart Health has acquired six medical practices — Generations Primary Care, MDVIP, Hopkinsville Family Care, Western Kentucky Pulmonary Clinic, Elkton Clinic, and Crofton Clinic — to expand access to primary and specialty care across western Kentucky. Patients will continue receiving care from the same providers at their current locations with no interruption in services, and MDVIP will maintain its existing direct primary care membership model. The acquisition strengthens provider coordination, improves specialist access, and supports the long-term stability of regional healthcare delivery in underserved rural and semi-rural Kentucky communities. (Link)
  19. Legend Senior Living Acquires Apple Blossom Senior Living in Moon Township, Pennsylvania, Expanding to 78 Residences Across Eight States as Part of Its Ongoing Pennsylvania Growth Strategy Legend Senior Living has acquired Apple Blossom Senior Living in Moon Township, Pennsylvania, as part of its ongoing Pennsylvania expansion. The community offers Independent Living cottages along with Personal Care and Memory Care options. With this addition, Legend now operates 78 senior living residences across eight states. The acquisition strengthens Legend’s presence in the greater Pittsburgh market and continues its family-led approach focused on personalized resident support, dignity, and quality of life. Legend’s acquisition strategy targets established communities in growing suburban markets where demand for senior living services is supported by favorable demographic trends. (Link)
  20. Imagen Dental Partners Adds Pineview Aesthetic & Family Dentistry in Bellevue, Washington, Expanding Its Pacific Northwest Presence with a Practice Founded in 2007 by Repeated Seattle Top Dentist Honoree Dr. Gannon Stahl Imagen Dental Partners has partnered with Pineview Aesthetic & Family Dentistry, a leading Bellevue, Washington practice founded in 2007 and led by Dr. Gannon Stahl, a University of Washington School of Dentistry graduate and repeated Seattle Top Dentist honoree. The practice offers comprehensive family, cosmetic, restorative, and implant dentistry using advanced clinical technology and a patient-first approach. Dr. Stahl will continue focusing on clinical excellence while gaining access to Imagen’s support infrastructure across recruiting, marketing, revenue cycle management, and operations — a structure consistent with the supported independence model common across dental service organization partnerships. (Link)
  21. New Jersey Medical Office Building and ASC Portfolio — Including Physician’s SurgiCenter — Sells for $13.6 Million; Two-Building Medical Portfolio in Toms River 99% Leased at Close A medical office building portfolio in Toms River, New Jersey, including Physician’s SurgiCenter, has sold for $13.6 million. The two-building Holiday City Medical Portfolio totals 55,680 square feet and was 99% leased at closing, with established tenants including Labcorp, University Radiology Group, Asetera Cancer Care, Premier Dermatology, Elite Podiatry, and several others. Horizon Equities sold the properties to an undisclosed buyer following strong investor interest, with nearly a dozen competing offers received. The transaction reflects continued investor appetite for stabilized, multi-tenant medical office and ambulatory surgery center assets in established suburban New Jersey healthcare markets. (Link)
  22. Group Benefit Services Acquires Integrity Administrators, a Sacramento, CA-Based Third-Party Administrator, Expanding Its Self-Funded Health Plan Administration Platform with Enhanced Nurse Navigator and Member Services Capabilities Group Benefit Services, Inc. (GBS) has acquired Integrity Administrators, Inc. (IAI), a third-party administrator based in Sacramento, California specializing in self-funded health plan administration. The combination enhances GBS’s platform with expanded resources, Nurse Navigator programs, and a high-touch service model focused on cost savings and member support. IAI clients will benefit from GBS’s broader infrastructure and national network while maintaining the personalized service approach that defines the IAI model. The transaction continues consolidation in the fragmented TPA market, where self-funded employers increasingly seek scaled administrators with clinical care coordination capabilities alongside traditional plan administration services. (Link)

Venture Deals and Other

  1. Samsung Electronics (KRX: 005930) has made a $175 million investment in Element Biosciences’ upsized Series E financing round, becoming the genomic and multiomic technology company’s largest shareholder, with an undisclosed amount from other co-investors also participating. Samsung Electronics (KRX: 005930) has committed $175 million into an upsized Series E financing round for Element Biosciences, a San Diego-based life sciences company specializing in DNA sequencing and multiomic technologies. Samsung, a longstanding investor in Element, will become its largest shareholder upon close, pending regulatory approvals. The investment reflects Samsung’s strategic confidence in Element’s growing product ecosystem — including AVITI, VITARI, and the forthcoming AVITI Dx and AVITI24 — and aligns with its broader precision medicine and life sciences innovation mandate. Proceeds will fund global commercialization, geographic expansion, and advancement of the company’s product roadmap across research, translational science, and diagnostic applications. (Link)
  2. Avataar Ventures has led a $28.5 million Series B round in Bengaluru-based deep-tech manufacturing startup Ethereal Machines, with participation from existing investor Peak XV Partners, to fund a new manufacturing facility, indigenous CNC technology development, and global market expansion. Bengaluru-based deep-tech firm Ethereal Machines has raised $28.5 million in a Series B round led by Avataar Ventures, with Peak XV Partners participating as a returning investor. The capital, arriving nearly two years after the company’s $13 million Series A, is earmarked to construct a new 300,000-square-foot automated manufacturing plant under an MOU with the Karnataka government, develop a proprietary multi-axis CNC controller, and expand into the U.S. and European markets. Ethereal Machines’ MaaS business has grown threefold year-on-year since its Series A and production capacity has expanded tenfold. The company targets sectors including aerospace, defense, semiconductor manufacturing, and consumer electronics. (Link)
  3. Echo Health Ventures and FMZ Ventures have co-led a $30 million Series C in InStride Health, with existing investors Valtruis, .406 Ventures, General Catalyst, and Mass General Brigham Ventures also participating, bringing the pediatric mental health company’s total raised to $86 million. InStride Health, a provider of insurance-based virtual specialty treatment for children, teens, and young adults with anxiety and OCD, has closed a $30 million Series C co-led by Echo Health Ventures — the strategic CVC arm of the Blue Cross Blue Shield collaborative network — and FMZ Ventures, a growth equity firm specializing in digitally enabled consumer marketplace companies. Existing investors Valtruis, .406 Ventures, General Catalyst, and Mass General Brigham Ventures also participated. The round brings InStride’s total capital raised to $86 million and will fund geographic expansion from 17 states to Midwest and Western markets and deepening of payer relationships with insurers including Aetna, Anthem, Cigna, and UnitedHealthcare. (Link)
  4. Index Ventures has led a $7 million seed round in Uncovr, with Seedcamp, Frst, No Labels Ventures, and Entrepreneurs First also participating, to fund the AI surgical documentation startup’s expansion across U.S. and European hospital systems. Uncovr, a surgical AI company that analyzes intraoperative video to automatically generate procedural coding and operative reports, has secured $7 million in seed funding led by Index Ventures, with Seedcamp, Frst, No Labels Ventures, and Entrepreneurs First among additional investors. Digital Surgery founder Jean Nehme, Color Health CEO Othman Laraki, and Meta board member Charlie Songhurst also contributed individually to the round. Uncovr, launched in 2025 and currently deployed across more than 400 operating rooms in the U.S. and Europe, has identified a 16% missed-billable-step rate and a ~10% reimbursement gap in procedures. The seed capital will be deployed to hire ML engineers and expand hospital partnerships. (Link)
  5. Bonfire Ventures, Supernode, Comma Capital, and individual investor Jacquelyn Kung have backed Vali Health with $6 million in funding as the San Francisco-based AI home care startup emerges from stealth. Vali Health, a San Francisco-based startup building AI infrastructure for the home care industry, has emerged from stealth with $6 million in funding from Bonfire Ventures, Supernode, Comma Capital, and individual investor Jacquelyn Kung. Founded by Serena Dang (CEO) and Jason Wu (CTO), Vali Health has built an AI-native 24/7 safety infrastructure designed to help mid-sized home care agencies automate workforce management and coordination, saving upwards of 20 hours per week. The startup has achieved 400% growth in just 12 months, now serving agencies across nearly 100 locations in 30 states. Capital will be used to expand operations and market reach. (Link)
  6. Vanna Health Raises $17 Million to Expand Evidence-Based Care for People Living with Serious Mental Illness Vanna Health, a value-based health technology company providing integrated mental and chronic health support through community-based coaching, has raised $17 million in funding co-led by a national healthcare insurer and AlleyCorp, with participation from Health Velocity Capital. The capital will support expansion of its clinical reach, technology infrastructure, and recovery-oriented care model for individuals with serious mental illness (SMI) such as schizophrenia and bipolar disorder. Vanna Health currently operates in four states and aims to scale its community-centered, technology-enabled approach nationwide. (Link)
  7. Khosla Ventures has led an $11 million seed round in Clair Health, with participation from a16z Speedrun, Brydge Club, Treehub, Cartan Capital, AGI House, Insiders VC, and Anne Wojcicki, to develop the first continuous, non-invasive wearable hormone monitor for women. Clair Health, a femtech startup co-founded by Stanford graduates Jenny Duan and Abhinav Agarwal, has raised $11 million in seed funding led by Khosla Ventures, with a16z Speedrun, Brydge Club, Treehub, Cartan Capital, AGI House, Insiders VC, and 23andMe co-founder Anne Wojcicki also contributing. The startup is building a wearable wristband leveraging a proprietary stack of 10 biosensors — including biomagnetic sensors not found in any competing consumer wearable — combined with AI models to continuously infer a woman’s hormonal cycle phase without blood draws or skin piercing. With a 25,000-person waitlist and a sold-out presale, Clair Health plans a November 2026 wellness product launch and subsequent pursuit of FDA clearance for applications across fertility, perimenopause, and hormone conditions. (Link)
Spenser Lin No Comments

Healthcare News, Deals, and Investments Update May 18th, 2026

LECO_Weekly-Healthcare-News_5-18-2026-1Download
  1. Boston Scientific Announces $1.5 billion Strategic Investment in MiRus LLC Boston Scientific Corporation (NYSE: BSX) announced a $1.5 billion strategic investment for an approximately 34% equity stake in MiRus LLC, a privately held company developing proprietary biomaterials, implants, and procedural solutions for cardiovascular and orthopedic diseases. Announced May 18, 2026, the agreement includes an exclusive option to acquire MiRus’ SIEGEL™ Balloon Expandable TAVR system, with potential additional payments of up to $3 billion upon clinical and regulatory milestones. The nickel-free, rhenium-alloy valve features a smaller delivery sheath, precise placement, and promising early clinical results in the ongoing STAR pivotal trial. The investment strengthens Boston Scientific’s interventional cardiology portfolio in the rapidly growing aortic stenosis market. (Link)
  2. J.P. Morgan, KKR, BofA Securities, and Barclays led the $478.7 million initial public offering of GMR Solutions (NYSE: GMRS) at a revised price of $15 per share GMR Solutions (NYSE: GMRS), the largest provider of emergency medical services in the U.S., priced its IPO at $15 per share, raising $478.7 million. The offering was led by a major syndicate including J.P. Morgan and KKR, with the latter also providing a $500 million concurrent private placement to bolster the company’s balance sheet. GMR Solutions plans to use the IPO proceeds primarily to pay down its existing debt. Despite the offering price being lowered from initial expectations, the IPO values the company at approximately $3.4 billion. The deal highlights significant institutional interest in the stabilization and growth potential of essential emergency and transport healthcare services. (Link)
  3. Prestige Consumer Healthcare (NYSE:PBH) Announces Acquisition of LaCorium Health Prestige Consumer Healthcare Inc. has entered into a definitive agreement to acquire LaCorium Health, a leading Australian platform in therapeutic skin care, lip, foot, and skin treatments. Announced May 13–14, 2026 alongside fiscal results, the approximately $150 million cash deal adds a high-growth, asset-light international OTC portfolio with strong market positions and expected double-digit revenue growth. The acquisition enhances Prestige’s dermatological offerings and geographic diversification. (Link)
  4. Lumexa Imaging (NASD: LMRI) executed its growth strategy by adding four new centers through joint ventures with University of Pittsburgh Medical Center (UPMC) and Advocate Health Lumexa Imaging the addition of four new locations in 2026, advancing its strategy to expand in high-growth markets via strategic partnerships. The expansion includes entry into the Pennsylvania market through a joint venture with the University of Pittsburgh Medical Center (UPMC) and further growth in the Southeast with Advocate Health. These additions, consisting of two acquisitions and two de novo centers, bring Lumexa’s total to over 190 outpatient imaging centers. The company leverages these joint ventures for capital efficiency and repeatability, focusing on the sustained shift toward outpatient, lower-cost sites of care driven by an aging population. (Link)
  5. Coastal Medical Transportation Systems Acquires Alert Ambulance to Expand New England Regional Care Network Coastal Medical Transportation Systems (CMTS), a leading privately owned medical transportation provider in New England, has completed the acquisition of Alert Ambulance Service. Announced May 18, 2026, the deal further strengthens CMTS’s position as one of the largest and most comprehensive ambulance and medical transportation providers in the region, following its prior integration of Fallon and Lifeline Ambulance Services. The acquisition expands geographic coverage across Massachusetts, New Hampshire, and Rhode Island, increases fleet size to over 325 vehicles, and grows the combined workforce to nearly 1,500 clinicians and support staff. (Link)
  6. Wellgistics Health (NASD: WGRX) Accelerates Digital Health Expansion with Planned Acquisition of WellCare Today Wellgistics Health, Inc. announced a non-binding letter of intent to acquire WellCare Today, a remote monitoring company specializing in RPM, RTM, and CCM programs powered by Samsung Galaxy Watch technology. Announced May 14, 2026, the proposed ~$15 million transaction (including $3 million cash and performance-based earnout in preferred stock) will integrate WellCare Today’s HealthAssist® platform with Wellgistics’ MSO pilot through Kare Clinicals and its network of over 6,500 independent pharmacies. The combination aims to enhance patient engagement, medication adherence, chronic care management, and reimbursement opportunities through wearable-enabled remote monitoring. (Link)
  7. Lorient Capital entered a strategic growth partnership with PeterMD to accelerate the national expansion of its proactive Medicine 3.0 healthcare platform Lorient Capital, a private equity firm exclusively focused on healthcare, has made a strategic investment in PeterMD to scale its personalized “Medicine 3.0” platform. PeterMD specializes in precision medicine, offering customized hormone health, longevity, and sexual wellness treatments through advanced diagnostics and proactive care. Lorient Capital is deploying capital from its $500 million Healthcare Fund III to fuel PeterMD’s national growth, aiming to transform the traditional reactive healthcare model. The partnership focuses on enhancing clinical outcomes and operational efficiency as PeterMD seeks to expand its footprint and bring precision-based integrated medicine to a broader national patient base. (Link)
  8. Blackstone and KKR & Co. Inc. reached a restructuring deal to take over the dental firm Affordable Care after slashing its total debt by 70% Direct lenders Blackstone and KKR are set to take control of Affordable Care, one of the largest U.S. dental services providers, following a major debt restructuring. The deal involves the lenders in a $1.4 billion private credit structure swapping their debt for equity, effectively slashing the dental firm’s debt load by approximately 70%. This restructuring provides Affordable Care with a significantly improved balance sheet to manage its extensive network of dental practices. The move underscores the increasing trend of major private credit lenders like Blackstone and KKR transitioning from creditors to equity owners to stabilize and preserve value in distressed healthcare portfolios. (Link)
  9. Quince Therapeutics (NASDAQ: QNCX)  Acquires Orphai Therapeutics and Raises up to $187 Million in Private Placement to Advance Pulmonary Pipeline Quince Therapeutics, Inc. announced the acquisition of Orphai Therapeutics, bringing in LAM-001, an inhaled formulation of rapamycin (sirolimus) for rare pulmonary diseases including pulmonary hypertension associated with interstitial lung disease (PH-ILD) and bronchiolitis obliterans syndrome (BOS). Concurrently, Quince entered a private placement to raise up to $187 million ($115 million upfront + up to $72 million from warrants), led by Balyasny Asset Management with participation from a strong syndicate of healthcare investors. The combined proceeds are expected to fund operations through the end of 2028 and support multiple clinical milestones, including Phase 2 data readouts in 2027 and 2028.
  10. Orthopaedic Specialty Group and OrthoConnecticut Merge to Create Statewide Physician-Led Platform Powered by HOPCo Technology Partnership Orthopaedic Specialty Group (OSG) and OrthoConnecticut have officially merged, creating a dominant, physician-led musculoskeletal (MSK) care platform across Connecticut. The merger is bolstered by a strategic partnership with Healthcare Outcomes Performance Company (HOPCo), the global leader in MSK value-based care. While the organizations merge their clinical networks to improve patient access, HOPCo provides the digital infrastructure, including advanced analytics and care management tools, to optimize outcomes and reduce total care costs. This collaboration allows the unified practice to scale thoughtfully while preserving clinical autonomy and delivering high-quality orthopedic services closer to home for patients throughout the Connecticut. (Link)
  11. Sweetser merged with Common Ties Mental Health Services to create Maine’s largest provider of Certified Community Behavioral Health Clinic services Common Ties Mental Health Services, based in Lewiston, has officially merged with Sweetser to create a robust behavioral health network in Maine. This merger establishes Sweetser as the state’s largest provider of Certified Community Behavioral Health Clinic (CCBHC) services, integrating Common Ties’ regional expertise into Sweetser’s broad statewide platform. The investment focuses on streamlining mental health delivery, expanding free community training, and increasing access to specialized behavioral health services. By consolidating resources, the combined entity aims to build a more sustainable and accessible care model to address the rising mental health needs across Maine’s diverse and often underserved communities. (Link)
  12. Gryphon Investors-backed LEARN Behavioral acquired Little Leaves Behavioral Services from FullBloom, a portfolio company of American Securities LEARN Behavioral, a leading autism therapy provider backed by Gryphon Investors, has acquired Little Leaves Behavioral Services from FullBloom. FullBloom is a portfolio company of American Securities and sold the division to refocus on its core educational services. Little Leaves operates 18 early-intervention centers across Maryland, Virginia, and Florida, which will now join LEARN’s extensive national network. This acquisition allows LEARN Behavioral to expand its density in the Mid-Atlantic and establish a larger presence in the Florida market. The deal represents a significant consolidation within the ABA (Applied Behavior Analysis) sector, focusing on scaling early-intervention services for children with autism. (Link)
  13. Arcadea Group expanded its mission-critical software presence in Brazil through the acquisition of hemotherapy and hospital software provider Sofis Arcadea Group, a long-term investor in high-quality software firms, has acquired Sofis, a Rio de Janeiro-based provider of healthcare software. Sofis specializes in mission-critical solutions for blood bank management (hemotherapy) and hospital ERP systems, serving over 300 institutions across Brazil. This acquisition marks Arcadea’s fourth investment in the Brazilian healthcare technology market. Arcadea plans to leverage its permanent capital base to support Sofis’ long-term product development and international expansion. By transitioning from a founder-owned model to one backed by Arcadea’s global resources, Sofis aims to modernize its platform and deepen its penetration into the complex Latin American healthcare technology landscape. (Link)
  14. Iterative Health Acquires Cardiology Research Sites from NextStage Clinical Research Iterative Health, a healthcare technology and services company focused on accelerating clinical research, has acquired three cardiology research sites from NextStage Clinical Research in Texas (Beaumont, Port Arthur, and Waco). Announced on May 14, 2026, with Bourne Partners serving as financial advisor, the deal expands Iterative Health’s elite site network and strengthens its capabilities in cardiovascular research — a therapeutic area affecting nearly half of U.S. adults. The sites bring experienced teams, strong community provider connections, and an active trial portfolio, enhancing patient access to innovative therapies while providing sponsors with high-performing, real-world research centers. (Link)
  15. HealthScape Advisors Acquires PayerAlly to Strengthen Pharmacy Benefit Management Capabilities HealthScape Advisors, a leading payer advisory firm and a Chartis company, has acquired PayerAlly, an independent pharmacy consulting firm specializing in pharmacy benefit management (PBM) strategy, procurement, and optimization. Announced May 12, 2026 (with coverage extending through mid-May), the deal enhances HealthScape’s ability to help health plans and employers address rapidly rising prescription drug costs through integrated, clinically informed total cost-of-care solutions. PayerAlly’s expertise in PBM strategy complements HealthScape’s broader payer advisory platform, supporting more effective management of one of healthcare’s fastest-growing expense categories. (Link)
  16. NeuroVision Acquires Durin Life Sciences to Advance Neurodegenerative Diagnostics NeuroVision, a diagnostics company developing early detection tools for Alzheimer’s and other neurodegenerative diseases, has acquired Durin Life Sciences, a fellow diagnostics developer. Announced May 15, 2026, the deal adds Durin’s blood-based Duritect™ tests for early detection and monitoring of Alzheimer’s, Parkinson’s, and ALS. The combination accelerates NeuroVision’s platform for earlier, more accessible diagnosis and disease management, addressing critical gaps in neurodegenerative care. (Link)
  17. IKS Health Acquires ARAI Solutions to Accelerate Agentic AI Capabilities IKS Health, a global leader in care enablement and AI-driven clinical solutions, has acquired ARAI Solutions, a specialized AI management and technology company focused on biomedical knowledge graphs and clinical reasoning infrastructure. Announced May 13–14, 2026, the deal enhances IKS Health’s ability to build proprietary small language models and agentic AI systems for clinical, operational, and revenue cycle workflows. ARAI’s ontology layer and applied research expertise will improve the reliability, auditability, and efficiency of IKS’s AI platforms serving health systems nationwide. (Link)
  18. Signant Health Acquires Ametris to Create End-to-End eCOA and Digital Outcome Measures Platform Signant Health, a leading evidence generation company for clinical trials, has acquired Ametris (formerly ActiGraph), a global digital health solutions provider specializing in wearable-derived clinical outcome measures. The deal integrates Signant’s eCOA (electronic Clinical Outcome Assessment) solutions with Ametris’ validated sensor-based technologies for objective measurement of physical activity and function. The combined platform will deliver multimodal evidence—patient-reported outcomes alongside continuous real-world data—simplifying complex trials, accelerating insights, and strengthening regulatory submissions, particularly in CNS and other therapeutic areas. (Link)
  19. iSpecimen Inc. (NASD: ISPC) Secures $2.5 Million Private Placement to Support Operations Amid 89% Annual Stock Decline iSpecimen Inc. finalized a $2.5 million private placement on May 11, 2026, to bolster working capital. The biospecimen marketplace provider, currently valued at $3.39 million, has seen its share price plummet 89% over the past year to $4.57. This funding follows a $5.5 million raise in late 2025, aimed at mitigating rapid cash burn. iSpecimen, which connects medical researchers with specimen providers, will use the proceeds for general corporate purposes as it navigates significant financial challenges and seeks to stabilize its market position. (Link)
  20. Blue Sea Capital supported One Physics in its strategic acquisition and partnership with Petrone Associates to expand its Northeast clinical services footprint One Physics, the largest outsourced medical physics services company in North America, has announced its 22nd acquisition with the addition of New York-based Petrone Associates. This strategic move, backed by growth-oriented private equity firm Blue Sea Capital, significantly strengthens One Physics’ presence in the New York City metropolitan market and Northern New Jersey. The partnership leverages One Physics’ national scale and Petrone’s established clinical reputation to provide comprehensive diagnostic and therapy medical physics, radiation safety, and dosimetry services. Blue Sea Capital, managing over $1.5 billion in assets, remains committed to accelerating One Physics’ industry leadership through continued regional consolidation. (Link)

Venture Deals and Other

  1. Sound Ventures, Alumni Ventures, Link Ventures, Redesign Health, and RRE Ventures invested $17 million in Anomaly Insights to address healthcare payer-provider information asymmetry. Anomaly Insights, an AI-powered payer intelligence firm, secured $17 million in funding led by Sound Ventures to combat the informational gap between healthcare payers and providers. The investment includes participation from RRE Ventures and Redesign Health, focusing on Anomaly’s real-time AI platform that identifies and corrects billing errors and payment inaccuracies. The company aims to reduce the massive administrative waste in the U.S. healthcare system by providing transparency in the claims process. This new capital will be used to enhance Anomaly’s machine learning models and scale its solutions across larger health systems and insurance networks to streamline payment cycles. (Link)
  2. McKesson Ventures, FCA Venture Partners, Sanofi Ventures, and AIX Ventures led a $26 million Series A for Branchlab to scale its AI-driven biopharma commercialization platform Branchlab raised $26 million in a Series A round led by McKesson Ventures to accelerate the growth of its Pathwai™ platform. The round, which included corporate venture backing from Sanofi Ventures, brings Branchlab’s total funding to $35 million. The company uses privacy-first AI to optimize the patient journey and enhance pharmaceutical commercialization, reporting a 70% increase in patient activation efficiency. Branchlab intends to use the capital to expand its engineering and data science teams in New York and Colorado. By providing real-time insights to biopharma brands, Branchlab aims to make pharmaceutical marketing more effective and patient-centric through advanced data analytics. (Link)
  3. AIX Ventures led a $2 million pre-Seed funding round for Chromie Health to develop its autonomous AI-powered hospital workforce management platform Chromie Health, a New York-based startup, secured $2 million in pre-Seed funding led by AIX Ventures to tackle the hospital staffing crisis. The company develops autonomous AI agents that automate complex administrative tasks and workforce scheduling without requiring deep IT integration. Chromie Health’s platform is designed to alleviate the burnout of clinical staff by handling the logistics of hospital operations through intelligent automation. The investment will support the development of additional “digital agents” capable of reasoning through clinical context and staffing needs. This seed capital positions Chromie Health to pilot its solutions across more health systems seeking to modernize their operational efficiency. (Link)
  4. Blueprint Equity, Villain Capital, Z21 Ventures, and Bienville Capital led a $14 million growth funding round for pediatric-focused AI operating system Develo Develo, an AI-native operating system for pediatric practices, raised $14 million in a funding round led by Blueprint Equity. The platform integrates clinical workflows, billing, and parent engagement into a single AI-driven ecosystem, currently serving hundreds of providers across 25 states. The capital will be used to accelerate the development of specialized AI tools, including automated charge capture and AI-assisted scribing for pediatricians. Develo aims to reduce the administrative burden that leads to physician burnout while improving the financial performance of independent pediatric practices. The investment highlights a growing trend toward specialty-specific AI platforms that address unique clinical and operational workflows. (Link)
  5. Thrive Capital, General Catalyst, Accel, Bain Capital Ventures, Redpoint, BoxGroup, and Pear VC backed Forus with $160 million to build its AI-powered pharmaceutical delivery network Forus, formerly known as Tandem, raised $160 million in a major funding round backed by top-tier venture firms including Thrive Capital and General Catalyst. The company is building an AI-powered infrastructure that connects doctors, pharmacies, and biopharma companies to streamline the drug fulfillment process. Forus automates the “last-mile” clinical steps, such as insurance authorizations, to ensure patients receive treatments faster. With five of the top ten global biopharma companies already utilizing the network, Forus plans to use the investment to expand its nationwide reach and further integrate its AI layer into existing physician and pharmacy workflows to eliminate treatment delays. (Link)
  6. Uncork Capital, Frist Cressey Ventures, Moxxie Ventures, and Coalition Operators provided $11.6 million in Seed funding for the launch of Knit Health’s clinical behavior AI Knit Health, a spin-out from UC Berkeley, launched with $11.6 million in Seed funding co-led by Uncork Capital and Frist Cressey Ventures. The company is developing a Large Clinical Behavior Model (LCBM) trained on real-world clinician decisions across 30 U.S. health systems. Knit Health’s AI agents are designed to handle triage, patient flow, and care coordination by learning from collective clinical experience rather than just static text. The funding will be used to scale its foundational intelligence layer and deploy AI agents that assist in high-stakes hospital environments. This investment reflects a shift toward “Action AI” that can reason and perform complex tasks in clinical settings. (Link)
  7. Salesforce Ventures, Echo Health Ventures, Susa Ventures, Matrix Partners, and HC9 Ventures raised $17.5 million in Series A funding for Optura’s AI governance platform Optura, a Nashville-based healthcare AI governance platform, secured $17.5 million in Series A funding led by Salesforce Ventures. The investment, which brings Optura’s total funding to $25 million, will support the expansion of its “Return on AI Investment” (ROAI) platform. Optura helps enterprise healthcare organizations, such as Independence Blue Cross, map fragmented data and measure the efficacy of their AI agents. The capital will be used to scale partnerships with LLM providers and grow its engineering teams. By providing a unified knowledge layer, Optura enables healthcare leaders to prioritize AI use cases based on actual operational readiness and projected business value. (Link)
  8. Norwest, Primary, Next Ventures, Constellation, and Scrub Capital led a $25 million financing round for Tokaido Health to launch its AI medication steerage platform. Tokaido Health emerged from stealth with $25 million in funding led by Norwest and Primary to address skyrocketing pharmacy costs for employers. The platform utilizes AI and behavioral economics to identify same-or-better medications that cost less, steering members toward high-value options like biosimilars. Tokaido layers on top of existing PBM stacks, allowing for a seamless integration without plan redesigns. The investment will be used to scale its concierge-style member outreach and expand its clinical reasoning engine. By focusing on site-of-care steerage and polypharmacy reconciliation, Tokaido aims to eliminate billions in wasted drug spending while improving the patient experience. (Link)
  9. Andera Partners, American Century Investments, Clarevia Ventures, Time BioVentures, View Ventures, Cadence Healthcare Ventures, and Anduril Investors led a $20 million Series D for Rivermark Medical Rivermark Medical, a urology-focused medical device company, raised $20 million in Series D funding led by Andera Partners. The financing will support the ongoing RAPID III pivotal clinical trial for the FloStent™ System, a non-surgical treatment for men with benign prostatic hyperplasia (BPH). The investment syndicate includes American Century Investments and Time BioVentures, focusing on bringing this reversible, office-based therapy to market. The FloStent is designed to be easily adjustable and tissue-preserving, offering a first-line alternative to more invasive surgical procedures. The capital will also be used to prepare for a U.S. commercial launch following expected regulatory approval. (Link)
  10. Aulis Capital led a $13.4 million Seed funding round for Shyld AI to accelerate the deployment of its autonomous AI-driven infection control solutions Shyld AI, a healthcare technology company, secured $13.4 million in Seed funding led by Aulis Capital to expand its active intelligence solutions for hospital facilities. Shyld AI develops autonomous physical agents that use AI and UV disinfection to reduce environmental contamination in high-risk areas like operating rooms. The funding will accelerate deployments across U.S. health systems and support the company’s expansion into regulated pharmaceutical manufacturing environments. By streamlining infection control and compliance without adding to the workload of hospital staff, Shyld AI aims to improve patient safety and operational efficiency. The investment marks a significant milestone in the adoption of autonomous hygiene agents in healthcare. (Link)

Sign up for all the Lawrence, Evans & Co., LLC news and activities
CLICK HERE